Insertional mutagenesis of the adeno-associated virus type 2 (AAV2) capsid gene and generation of AAV2 vectors targeted to alternative cell-surface receptors

Human Gene Therapy

Volumn 12, Issue 14, 2001, Pages 1697-1711

  Arnold, Gregory S ^a   Bartlett, Jeffrey S ^a,b,c   Shi, Wenfang ^c  

^a NATIONWIDE CHILDREN S HOSPITAL   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c Columbus State University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; CAPSID PROTEIN; CELL SURFACE RECEPTOR; EPITOPE; LUTEINIZING HORMONE RECEPTOR; PEPTIDE; PROGESTERONE; PROTEOHEPARAN SULFATE; VIRUS VECTOR;

ADENO ASSOCIATED VIRUS; AMINO ACID SEQUENCE; ARTICLE; CANCER CELL CULTURE; CELL LINE; CONTROLLED STUDY; EMBRYO; FEMALE; GENE INSERTION; GENE TARGETING; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; OVARY CARCINOMA; PHENOTYPE; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RECEPTOR BINDING; VIRUS CAPSID; VIRUS CHARACTERIZATION; VIRUS CLASSIFICATION; VIRUS MUTANT; VIRUS PARTICLE; VIRUS RECOMBINANT; VIRUS VIRULENCE;

BINDING SITES; CAPSID; DEPENDOVIRUS; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROPHORESIS, POLYACRYLAMIDE GEL; EPITOPES; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HELA CELLS; HEPARIN; HUMANS; IMMUNOBLOTTING; LIGANDS; MODELS, BIOLOGICAL; MUTAGENESIS, SITE-DIRECTED; MUTATION; PHENOTYPE; PLASMIDS; PROGESTERONE; PROTEIN BINDING; TRANSDUCTION, GENETIC; TUMOR CELLS, CULTURED;

EID: 0034814413     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/104303401750476212     Document Type: Article

References (43)

1. Steroid release from two human epithelial ovarian tumors: Evidence for an intrinsic production in vitro
2. The structure of human parvovirus B19 at 8 Å resolution
3. Functional implications of the structure of the murine parvovirus, minute virus of mice
4. Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model
5. Prospects for the development of targeted adeno-associated virus (AAV) vector systems
6. Selective and rapid uptake of adeno-associated virus type 2 in brain
7. Targeted adeno-associated virus vector transduction of nonpermissive cells mediated by a bispecific F(ab′γ)2 antibody
8. Infectious entry pathway of adeno-associated virus and adeno-associated virus vectors
9. Structure, sequence, and function correlations among parvoviruses
10. Cloning of adeno-associated virus type 4 (AAV4) and generation of recombinant AAV4 particles
11. Prediction of the secondary structure of proteins from their amino acid sequence
12. A stable cell line carrying adenovirus-inducible rep and cap genes allows for infectivity titration of adeno-associated virus vectors
13. Highly purified recombinant adeno-associated virus vectors are biologically active and free of detectable helper and wild type viruses
14. An algorithm for protein secondary structure prediction based on class prediction
15. Polarity influences the efficiency of recombinant adenoassociated virus infection in differentiated airway epithelia
16. GOR method for predicting protein secondary structure from amino acid sequence
17. Genetic capsid modifications allow efficient re-targeting of adeno-associated virus type 2
18. Recombinant adeno-associated virus-mediated gene transfer into hematopoietic progenitor cells
19. Characteristics of a human cell line transformed by DNA from human adenovirus type 5
20. Titration of AAV-2 particles via a novel capsid ELISA: Packaging of genomes can limit production of recombinant AAV-2
21. Experimental model systems of ovarian cancer: Applications to the design and evaluation of new treatment approaches
22. Genetics of adeno-associated virus: Isolation and preliminary characterization of adeno-associated virus type 2 mutants
23. Adeno-associated virus proteins: Origin of the capsid components
24. Interaction, signal generation, signal divergence, and signal transduction of LH/CG and the receptor
25. In vivo selection of sFv from phage display libraries
26. Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vector
27. Review: Gonadotropins and development of ovarian cancer
28. Role for highly regulated rep gene expression in adeno-associated virus vector production
29. Three-dimensional structure of Aleutian mink disease parvovirus: Implications for disease pathogenicity
30. Gene therapy against an experimental glioma using adeno-associated virus vectors
31. Insertional mutagenesis of AAV2 capsid and the production of recombinant virus
32. Assembly of viruslike particles by recombinant structural proteins of adeno-associated virus type 2 in insect cells
33. Use of a recombinant retrovirus to study post-implantation cell lineage in mouse embryos
34. Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions
35. Genetic analysis of adeno-associated virus: Properties of deletion mutants constructed in vitro and evidence for an adeno-associated virus replication function
36. The three-dimensional structure of canine parvovirus and its functional implications
37. Intermediates of adeno-associated virus type 2 assembly: Identification of soluble complexes containing Rep and Cap proteins
38. Mutational analysis of the adeno-associated virus type 2 (AAV2) capsid gene and construction of AAV2 vectors with altered tropism
39. Production of high-titer recombinant adeno-associated virus vectors in the absence of helper adenovirus
40. Development of novel cell surface CD34-targeted recombinant adeno-associated virus vectors for gene therapy
41. In vitro packaging of adeno-associated virus DNA
42. Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield